Timothy J. Sangiovanni
CIK: 0001698328
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZEVRA THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- May 28, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
40K shares- - May 28, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Unit
20K shares- - Feb 3, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Sale(S)Direct3K shares at avg. $9.18$28K - Jan 31, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Exercise(M)Direct11.7K shares- - Jan 30, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Exercise(M)Direct6.3K shares- - Jan 30, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Sale(S)Direct1.8K shares at avg. $8.82$15K - Feb 13, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
Sale(S)Direct3K shares at avg. $7.86$24K - Jan 31, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
Exercise(M)Direct11.7K shares- - Jan 30, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
38K shares- - Jan 30, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Unit
19K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 28, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 40,000 | - | - | Direct |
| May 28, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Restricted Stock Unit | 20,000 | - | - | Direct |
| Feb 3, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale(S) | 3,000 | $9.18 | $27,548 | Direct |
| Jan 31, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Exercise(M) | 11,666 | - | $0 | Direct |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Exercise(M) | 6,333 | - | $0 | Direct |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale(S) | 1,750 | $8.82 | $15,442 | Direct |
| Feb 13, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale(S) | 3,000 | $7.86 | $23,588 | Direct |
| Jan 31, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Exercise(M) | 11,666 | - | - | Direct |
| Jan 30, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 38,000 | - | - | Direct |
| Jan 30, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Restricted Stock Unit | 19,000 | - | - | Direct |
1-10 of 10 transactions
About Sangiovanni Timothy J.
Sangiovanni Timothy J. (SEC CIK 0001698328) files insider reports with the SEC as SVP, Finance & Corp Controller of ZEVRA THERAPEUTICS, INC. (ZVRA).
Signal8 holds 5 ownership filings by Sangiovanni Timothy J., all Form 4s, filed between Feb 3, 2025 and May 29, 2026. Those filings report 10 transactions, from Jan 30, 2025 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sangiovanni Timothy J.'s filings is in CELEBRATION, FL.
Recent filings by Sangiovanni Timothy J.
- May 28, 2026: Grants or awards of ZVRA derivative securities (2 lines, Form 4, code A).
- Feb 3, 2026: Open-market sale of ZVRA shares (Form 4, code S).
- Jan 31, 2026: Option exercise of ZVRA shares (Form 4, code M).
- Jan 30, 2026: Option exercise of ZVRA shares (Form 4, code M).
- Jan 30, 2026: Open-market sale of ZVRA shares (Form 4, code S).
Other insiders filing for ZEVRA THERAPEUTICS, INC. (ZVRA)
- McFarlane Neil F., President and CEO
- Thompson Rahsaan, Chief Legal & Compliance
- Watton Corey Michael, Director
- FAVORITO TAMARA A, Director
- Secor Alicia, Director
- Calder Douglas W, Director